Clinical Trial

Stony Brook Medicine Anti-Inflammatory Trial

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is an experimental study designed to measure the effect of celecoxib or minocycline on depressive symptoms in unipolar and bipolar depression. Participants will be equally randomized to either celecoxib or minocycline. All participants will complete a battery of clinical and psychological assessments prior to treatment assignment, and again after treatment completion, to assess any changes or improvements in depression.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-19; most recent amendment 2026-04-21.
Trial Details
NCT Number NCT06699966
Lead Sponsor Stony Brook University
Conditions Major Depressive Disorder
Enrollment 42 participants
Start Date 2027-06
Primary Completion 2031-06 (estimated)
Study Completion 2032-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-23